Development and internal validation of a risk prediction model for refractory hypoalbuminemia in peritoneal dialysis patients to guide nutritional intervention
- 1Department of Nephrology, The Second Hospital of Hebei Medical University, Hebei, China
Abstract
Background: Hypoalbuminaemia is closely related to poor prognosis in patients with PD. In clinical practice, we found that hypoalbuminemia is difficult to correct and persists longer in some PD patients. The primary purpose of this study was to analyze the cause of refractory hypoalbuminemia in PD patients and construct a clinical prediction model to help identify these patients at an early stage.
Methods: we retrospectively enrolled PD patients treated at the Second Hospital of Hebei Medical University between January 2021 and January 2023. Clinical data, laboratory results, peritoneal equilibration test (4hD/Pcr), and peritoneal protein excretion rate were collected. Patients were divided into modeling and internal validation cohorts. Risk factors were screened by LASSO regression and included in a multivariable logistic model to construct a nomogram. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA).
Results: a total of 368 PD patients were included, of whom 132 (35.9%) had refractory hypoalbuminemia. Independent risk factors included diabetes mellitus, elevated C-reactive protein (CRP), and high 4hD/Pcr; protective factors included higher BMI, triglycerides ≥1.265 mmol/L, HDL-C, and LDL-C. Peritoneal protein excretion rate was significantly higher in patients with refractory hypoalbuminemia and those with diabetes, and positively correlated with 4hD/Pcr (r = 0.6, P < 0.001). The prediction model showed excellent discrimination in the modeling cohort (AUC = 0.939) and internal validation cohort (AUC = 0.930), with good calibration and clinical net benefit. This study identifies key risk factors for refractory hypoalbuminemia in PD patients and presents a validated prediction model with high accuracy and clinical utility.
Conclusion: this study identifies key risk factors for refractory hypoalbuminemia in PD patients and presents a internal validated prediction model with high accuracy and clinical utility, which can guide early intensive nutritional intervention.
Related
- Development and External Validation of Machine Learning Models for Ionized Calcium Estimation in Hypoalbuminemia
- Development and internal validation of a clinical prediction model for postoperative venous thromboembolism after neurosurgical intervention in patients with traumatic brain injury
- Machine Learning-Based Prediction of Intervention-Free Survival After Surgery for Adenomyosis: Development and Internal Validation of a Prognostic Model
- Development and content validation of a risk-stratified nursing intervention programme for the prevention of healthcare-associated infections
- Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
BibTeX
@article{zhang2026development,
title = {{Development and internal validation of a risk prediction model for refractory hypoalbuminemia in peritoneal dialysis patients to guide nutritional intervention}},
author = {Limin Zhang and Desen Duan and Suyu Lu and Min Wang and Yujie Wang and Huaying Pei},
journal = {Frontiers in Nutrition},
year = {2026},
month = oct,
doi = {10.3389/fnut.2026.1950177},
url = {https://doi.org/10.3389/fnut.2026.1950177},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Development and internal validation of a risk prediction model for refractory hypoalbuminemia in peritoneal dialysis patients to guide nutritional intervention
AU - Limin Zhang
AU - Desen Duan
AU - Suyu Lu
AU - Min Wang
AU - Yujie Wang
AU - Huaying Pei
PY - 2026
DA - 2026/10/29
JO - Frontiers in Nutrition
DO - 10.3389/fnut.2026.1950177
UR - https://doi.org/10.3389/fnut.2026.1950177
AB - Background: Hypoalbuminaemia is closely related to poor prognosis in patients with PD. In clinical practice, we found that hypoalbuminemia is difficult to correct and persists longer in some PD patients. The primary purpose of this study was to analyze the cause of refractory hypoalbuminemia in PD patients and construct a clinical prediction model to help identify these patients at an early stage. Methods: we retrospectively enrolled PD patients treated at the Second Hospital of Hebei Medical University between January 2021 and January 2023. Clinical data, laboratory results, peritoneal equilibration test (4hD/Pcr), and peritoneal protein excretion rate were collected. Patients were divided into modeling and internal validation cohorts. Risk factors were screened by LASSO regression and included in a multivariable logistic model to construct a nomogram. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA). Results: a total of 368 PD patients were included, of whom 132 (35.9%) had refractory hypoalbuminemia. Independent risk factors included diabetes mellitus, elevated C-reactive protein (CRP), and high 4hD/Pcr; protective factors included higher BMI, triglycerides ≥1.265 mmol/L, HDL-C, and LDL-C. Peritoneal protein excretion rate was significantly higher in patients with refractory hypoalbuminemia and those with diabetes, and positively correlated with 4hD/Pcr (r = 0.6, P < 0.001). The prediction model showed excellent discrimination in the modeling cohort (AUC = 0.939) and internal validation cohort (AUC = 0.930), with good calibration and clinical net benefit. This study identifies key risk factors for refractory hypoalbuminemia in PD patients and presents a validated prediction model with high accuracy and clinical utility. Conclusion: this study identifies key risk factors for refractory hypoalbuminemia in PD patients and presents a internal validated prediction model with high accuracy and clinical utility, which can guide early intensive nutritional intervention.
SN - 2296-861X
ER -